---
name: ESTEVE CDMO
slug: esteve-cdmo
site: cdmo
website_domain: esteve.com
summary: ESTEVE CDMO is adding manufacturing capacity in the USA and China, including a $33 million expansion at its Morton Grove, Illinois site. Its China investment adds three manufacturing workshops with 250 m³ of total reaction volume, and its US assets add early development capabilities. Headquartered in Morton Grove, United States.
tagline: Global CDMO expanding manufacturing in the USA and China, with early development capabilities added in the US
founded_year: 
employee_count_band: 
employee_count_label: 
parent_name: 
parent_slug: 
hq_country: US
tier2_domain_verified: false
updated_at: 2026-10-22T00:02:16.569Z
services_count: 0
modalities_count: 0
indications_count: 0
locations_count: 2
review_signal_gate: closed
generated_by: BioBM Editorial AI
---

# ESTEVE CDMO

Global CDMO expanding manufacturing in the USA and China, with early development capabilities added in the US

Listed on cdmo.directory.

## Summary

ESTEVE CDMO is adding manufacturing capacity in the USA and China, including a $33 million expansion at its Morton Grove, Illinois site. Its China investment adds three manufacturing workshops with 250 m³ of total reaction volume, and its US assets add early development capabilities. Headquartered in Morton Grove, United States.

## At a glance

- HQ country: US

## Locations

- Morton Grove, Morton Grove, Illinois, USA
- China manufacturing site, China

## Long description

## ESTEVE CDMO

ESTEVE CDMO is the contract development and manufacturing business of ESTEVE, an international specialty pharmaceutical group with a strong European presence. The CDMO business is presented as a separate service line with its own contact page.

### Manufacturing footprint

- **China:** ESTEVE CDMO has announced a investment of more than $80 million in a new site in China, adding three manufacturing workshops and 250 m³ of total reaction volume to its global manufacturing network. The company notes more than 20 years of manufacturing presence in China.
- **United States:** ESTEVE CDMO has announced an additional $17.5 million investment in its Morton Grove, Illinois site, bringing the total announced investment there to $33 million.

### Development capabilities

- The company reports that its CDMO business is growing with new assets in the USA that add early development capabilities.

### Corporate context

- ESTEVE reports that expansion in both its Pharma and CDMO businesses has supported double-digit growth in net revenues and EBITDA.
- The company has achieved B Corp Certification.

_Profile last updated: 2026-10-22T00:02:16.569Z. Profile facts may include AI-assisted enrichment._

Auto-generated by BioBM Editorial AI for machine-readable profile access.